Reversal of Diabetes Insipidus in Brattleboro Rats: Intrahypothalamic Injection of Vasopressin mRNA

Characterization of oligonucleotide transport into living cells.

Loke, S. L., Stein, C. A., Zhang, X. H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J. S., & Neckers, L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3474 · Cited by 734

Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats

Schmale, H., & Richter, D. (1984) · Nature · doi:10.1038/308705a0 · Cited by 397

Parsimony Analysis in Historical Biogeography and Coevolution: Methodological and Theoretical Update

Brooks, D. R. (1990) · Systematic Zoology · doi:10.2307/2992205 · Cited by 264

Tissue-specific expression of mouse α-amylase genes

Schibler, U., Tosi, M., Pittet, A.-C., Fabiani, L., & Wellauer, P. K. (1980) · Journal of Molecular Biology · doi:10.1016/0022-2836(80)90208-9 · Cited by 187

Axonal transport of neuropeptide encoding mRNAs within the hypothalamo‐hypophyseal tract of rats.

Mohr, E., Fehr, S., & Richter, D. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07781.x · Cited by 165

The Vasopressin mRNA Poly(A) Tract is Unusually Long and Increases during Stimulation of Vasopressin Gene Expression in Vivo

Carrazana, E. J., Pasieka, K. B., & Majzoub, J. A. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.6.2267-2274.1988 · Cited by 149

mRNA coding for oxytocin is present in axons of the hypothalamo-neurohypophysial tract.

Jirikowski, G. F., Sanna, P. P., & Bloom, F. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7400 · Cited by 149

Vasopressin Gene Expression in the Rodent Hypothalamus: Transcriptional and Posttranscriptional Responses to Physiological Stimulation

Murphy, D., & Carter, D. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-7-1051 · Cited by 103

Regulation of poly(A) tail size of vasopressin mRNA.

Zingg, H. H., Lefebvre, D. L., & Almazán, G. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37914-6 · Cited by 96

Independent Regulation of Neuropeptide mRNA Level and Poly(A) Tail Length

Carter, D., & Murphy, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83468-8 · Cited by 89

Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering

Badieyan, Z. S., & Evans, T. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0259 · Cited by 37

RNA-based therapy for osteogenesis

Wang, P., Perche, F., Logeart‐Avramoglou, D., & Pichon, C. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118594 · Cited by 38

Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease

Hadas, Y., Katz, M. G., Bridges, C. R., & Zangi, L. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1367 · Cited by 37

In Vivo Gene Transfer Studies on the Regulation and Function of the Vasopressin and Oxytocin Genes

Murphy, D., & Wells, S. E. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.00964.x · Cited by 38

In vivo and ex vivo gene transfer to the brain

Fisher, L. J., & Ray, J. (1994) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(94)90017-5 · Cited by 37

Synthetic mRNA – emerging new class of drug for tissue regeneration

Balmayor, E. R. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.10.015 · Cited by 36

Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics

Yang, W., Cao, J., Cheng, H., Chen, L., Yu, M., Chen, Y., & Cui, X. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.11.014 · Cited by 36

Engineering Lipid Nanoparticles for mRNA Immunotherapy

Zwolsman, R. C., Darwish, Y. B., Kluza, E., & van der Meel, R. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70007 · Cited by 38

Influenza Viruses: Innate Immunity and mRNA Vaccines

Lee, S., & Ryu, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.710647 · Cited by 36

mRNA‐based chimeric antigen receptor T cell therapy: Basic principles, recent advances and future directions

Xiao, K., Lai, Y., Yuan, W., Li, S., Liu, X., Xiao, Z., & Xiao, H. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20230036 · Cited by 36

Nucleic acid drug and delivery techniques for disease therapy: Present situation and future prospect

Wang, T., Tang, Y., Tao, Y., Zhou, H., & Ding, D. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20230041 · Cited by 33

An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo

Rahman, M. M., Zhou, N., & Huang, J. (2021) · Vaccines · doi:10.3390/vaccines9030244 · Cited by 32

In Vitro-Transcribed (IVT)-mRNA CAR Therapy Development

Miliotou, Α. N., & Papadopoulou, L. C. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0146-4_7 · Cited by 32

Antisense drug delivery through the blood-brain barrier

Boado, R. J. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00006-s · Cited by 32

Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders

Arjunan, P., Kathirvelu, D., Mahalingam, G., Goel, A., Zacharaiah, U. G., Srivastava, A., & Marepally, S. K. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.04.015 · Cited by 33

mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration

Chanda, P. K., Sukhovershin, R. A., & Cooke, J. P. (2021) · Cells · doi:10.3390/cells10010187 · Cited by 30

RNA therapeutics for cardiovascular disease

Boada, C., Sukhovershin, R. A., Pettigrew, R. I., & Cooke, J. P. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000850 · Cited by 31

Vasopressin Antisense Oligonucleotide Induces Temporary Diabetes Insipidus in Rats

Skutella, T., Probst, J. C., Engelmann, M., Wotjak, G. T., Landgraf, R., & Jirikowski, G. F. (1994) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1994.tb00561.x · Cited by 30

Organ-targeted high-throughput in vivo biologics screen identifies materials for RNA delivery

Chang, T.-Y., Shi, P., Steinmeyer, J. D., Chatnuntawech, I., Tillberg, P. W., Love, K. T., Eimon, P. M., Anderson, D. G., & Yanik, M. F. (2014) · Integrative Biology · doi:10.1039/c4ib00150h · Cited by 29

The notorious R.N.A. in the spotlight - drug or target for the treatment of disease

Reautschnig, P., Vogel, P., & Stafforst, T. (2016) · RNA Biology · doi:10.1080/15476286.2016.1208323 · Cited by 30

Vasculature organotropism in drug delivery

Amruta, A., Iannotta, D., Cheetham, S. W., Lammers, T., & Wolfram, J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115054 · Cited by 29

Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing Arginine–Vasopressin in brattleboro rats

Ideno, J., Mizukami, H., Honda, K., Okada, T., Hanazono, Y., Kume, A., Saito, T., Ishibashi, S., & Ozawa, K. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.08.019 · Cited by 29

Reduction of exogenous vasopressin RNA poly(A) tail length increases its effectiveness in transiently correcting diabetes insipidus in the Brattleboro rat.

Maciejewski-Lenoir, D., Jirikowski, G. F., Sanna, P. P., & Bloom, F. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1435 · Cited by 29

mRNA as a Novel Treatment Strategy for Hereditary Spastic Paraplegia Type 5

Hauser, S., Poenisch, M., Schelling, Y., Höflinger, P., Schuster, S., Teegler, A., Betten, R., Gustafsson, J.-Å., Hübener‐Schmid, J., Schlake, T., et al. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.10.011 · Cited by 28

Engineering customized nanovaccines for enhanced cancer immunotherapy

Guo, J., Liu, C., Qi, Z., Qiu, T., Zhang, J. C., & Yang, H. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.02.028 · Cited by 27

Runx1 Messenger RNA Delivered by Polyplex Nanomicelles Alleviate Spinal Disc Hydration Loss in a Rat Disc Degeneration Model

Chang, C.-C., Tsou, H., Chang, H.-H., Chan, L. Y., Zhuo, G., Maeda, T., & Lin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010565 · Cited by 27

New perspectives for gene therapy in endocrinology

Barzon, L., Bonaguro, R., Palù, G., & Boscaro, M. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430447 · Cited by 27

Antisense Vasopressin Oligonucleotides: Uptake, Turnover, Distribution, Toxicity and Behavioral Effects

Meeker, R. B., LeGrand, G., Ramirez, J. J., Smith, T., & Shih, Y. (1995) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1995.tb00778.x · Cited by 27

Advancing mRNA technologies for therapies and vaccines: An African context

Kairuz, D., Samudh, N., Ely, A., Arbuthnot, P., & Bloom, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1018961 · Cited by 25

Tackling pharmacological response heterogeneity by PBPK modeling to advance precision medicine productivity of nanotechnology and genomics therapeutics

Vizirianakis, I. S., Miliotou, Α. N., Mystridis, G. A., Andriotis, E. G., Andreadis, I. I., Papadopoulou, L. C., & Fatouros, D. G. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1605828 · Cited by 25

In vivo protein expression from mRNA delivered into adult rat brain

Karikó, K., Keller, J. M., Harris, V. A., Langer, D. J., & Welsh, F. A. (2001) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(00)00355-1 · Cited by 24

Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach

Goyal, F., Chattopadhyay, A., Navik, U., Jain, A., Reddy, P. H., Bhatti, G. K., & Bhatti, J. S. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300255 · Cited by 25

Vasopressin and oxytocin gene expression in intact rats and under catecholamine deficiency during ontogenesis

Trembleau, A., Ugrumov, M. V., Roche, D. M. J., & Calas, A. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00020-f · Cited by 24

Antisense Oligonucleotides in the Study of Neuroendocrine Systems

Morris, M., & Lucion, A. B. (1995) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1995.tb00787.x · Cited by 24

mRNA delivery technologies: Toward clinical translation

Gómez-Aguado, I., Rodríguez-Castejón, J., Beraza-Millor, M., Rodríguez‐Gascón, A., del Pozo‐Rodríguez, A., & Solinís, M. Á. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.010 · Cited by 23

Cellular and Subcellular Evidence for Neuronal Interaction between the Chemokine Stromal Cell-Derived Factor-1/CXCL 12 and Vasopressin: Regulation in the Hypothalamo-Neurohypophysial System of the Brattleboro Rats

Callewaere, C., Fernette, B., Raison, D., Méchighel, P., Burlet, A. J., Calas, A., Kitabgi, P., Parsadaniantz, S. M., & Rostène, W. H. (2007) · Endocrinology · doi:10.1210/en.2007-1097 · Cited by 23

Null Mutation of the Arginine-Vasopressin Gene in Rats Slows Attentional Engagement and Facilitates Response Accuracy in a Lateralized Reaction Time Task

Jentsch, J. D., Arguello, P. A., & Anzivino, L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300194 · Cited by 23

Successful Survival of Grafted Transgenic Neural Plate Cells in Adult Central Nervous System Environment

Uchida, K., Roach, A., Kawaja, M. D., & Toya, S. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006916624755 · Cited by 22

Extrahypothalamic Expression of the Vasopressin and Oxytocin Genes

Murphy, D., Funkhouser, J. M., ANG, H., Foo, N.-C., & Carter, D. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb55540.x · Cited by 22

Localization of tyrosine hydroxylase mRNA in the axons of the hypothalamo-neurohypophysial system

Skutella, T., Probst, J. C., Blanco, E. J., & Jirikowski, G. F. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90224-0 · Cited by 22

Current Trends in Messenger RNA Technology for Cancer Therapeutics

Afzal, A., Abbasi, M. H., Ahmad, S., Sheikh, N., & Khawar, M. B. (2025) · Biomaterials Research · doi:10.34133/bmr.0178 · Cited by 21

mRNA Vaccine - A New Cancer Treatment Strategy

Tan, T., Deng, S., Wu, B.-H., Yang, Q., Wu, M., Wu, H., Cao, C., & Xu, C. S. (2023) · Current Cancer Drug Targets · doi:10.2174/1568009623666230222124424 · Cited by 22

mRNA Vaccine Platform: mRNA Production and Delivery

Litvinova, V. R., Рудометов, А. П., Карпенко, Л. И., & Ilyichev, A. A. (2023) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162023020152 · Cited by 26

Better, Faster, Stronger: mRNA Vaccines Show Promise for Influenza Vaccination in Older Adults

Bartley, J. M., Cadar, A. N., & Martin, D. E. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1909617 · Cited by 21

Virus‐Mimic mRNA Vaccine for Cancer Treatment

Meng, C., Chen, Z., Mai, J., Shi, Q., Tian, S., Hinkle, L. E., Li, J., Zhang, Z., Ramirez, M., Zhang, L., et al. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100144 · Cited by 21

Safe and effective aerosolization of in vitro transcribed mRNA to the respiratory tract epithelium of horses without a transfection agent

Legere, R. M., Cohen, N. D., Poveda, C., Bray, J. M., Barhoumi, R., Szule, J. A., de la Concha-Bermejillo, A., Bordin, A. I., & Pollet, J. (2021) · Scientific Reports · doi:10.1038/s41598-020-79855-1 · Cited by 20

Transgenic neural plate contributes neuronal cells that survive greater than one year when transplanted into the adylt mouse central nervous system

Uchida, K., Kawaja, M. D., Toya, S., & Roach, A. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90025-x · Cited by 20

Pharmacokinetics of antisense analogues in the central nervous system

Szklarczyk, A., & Kaczmarek, L. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00111-8 · Cited by 19

Business: The billion-dollar biotech

Dolgin, E. (2015) · Nature · doi:10.1038/522026a · Cited by 19

Non-Viral Delivery of Gene Therapy to the Tendon

Jin, J., Yang, Q., & Zhou, Y. L. (2022) · Polymers · doi:10.3390/polym14163338 · Cited by 18

Profile of Katalin Karikó and Drew Weissman: 2023 Nobel laureates in Physiology or Medicine

Krammer, F., & Palese, P. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2400423121 · Cited by 19

Current knowledge on the tissue distribution of mRNA nanocarriers for therapeutic protein expression

Zadory, M., Lopez, E., Babity, S., Gravel, S., & Brambilla, D. (2022) · Biomaterials Science · doi:10.1039/d2bm00859a · Cited by 18

Transgene expression of plasmid DNAs directed by viral or neural promoters in the rat brain

Djebbara-Hannas, Z., Didier‐Bazès, M., Sacchettoni, S., Prod'hon, C., Jouvet, M., Belin, M., & JACQUEMONT, B. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00276-8 · Cited by 18

Delivery of mRNA for cancer therapy: progress and prospects

Su, L.-J., Xu, M.-X., Ji, Z.-H., Zhu, J.-Q., Yu, M., Wang, Y., & Lin, Y. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102013 · Cited by 17

Delivery of mRNA Using Biomimetic Vectors: Progress and Challenges

Yin, M., Sun, H., Li, Y., Zhang, J., Wang, J., Liang, Y., & Zhang, K. (2024) · Small · doi:10.1002/smll.202402715 · Cited by 18

Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?

Tadic, S., & Martı́nez, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1433185 · Cited by 19

Nano-Encapsulation and Conjugation Applied in the Development of Lipid Nanoparticles Delivering Nucleic Acid Materials to Enable Gene Therapies

Đinh, L., Mahon, L., & Yan, B. (2024) · Applied Nano · doi:10.3390/applnano5030011 · Cited by 18

mRNA vaccine development and applications: A special focus on tumors (Review)

Chen, B., Yang, Y., Wang, X., Yang, W., Lu, Y., Wang, D., Zhuo, E., Tang, Y., Su, J., Tang, G., et al. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5669 · Cited by 17

Identification of a Potential mRNA‐based Vaccine Candidate against the SARS‐CoV‐2 Spike Glycoprotein: A Reverse Vaccinology Approach

Durojaye, O. A., Sedzro, D. M., Idris, M. O., Yekeen, A. A., Fadahunsi, A. A., & Alakanse, O. S. (2022) · ChemistrySelect · doi:10.1002/slct.202103903 · Cited by 16

Quo vadis: extrasomatic targeting of neuronal mRNAs in mammals

Kindler, S., Mohr, E., & Richter, D. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)04015-x · Cited by 16

Messenger RNA (mRNA) based therapeutics in transforming cardiovascular care: Progress, regulatory challenges and future perspectives

Khan, M., Musazzi, U. M., Manellari, S., Mouawad, N., Damiano, G., Rinaldi, R., Raucci, A., Costantino, S., Paneni, F., Minghetti, P., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107847 · Cited by 16

Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer

Hochmann, S., Mittermeir, M., Santic, R., Koszik, F., Griessner, L., Sonderegger, A., Hoffmann, T., Russe, E., Scheiblhofer, S., Weiss, R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31061-w · Cited by 15

RNA solutions to treat inborn errors of metabolism

Martínez‐Pizarro, A., & Desviat, L. R. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.07.006 · Cited by 15

mRNA-based personalized cancer vaccines: opportunities, challenges and outcomes

Ibragimova, A. A., Fedorov, A. A., Kirilenko, K. M., Чойнзонов, Е. Л., Denisov, E. V., & Patysheva, M. R. (2025) · Acta Naturae · doi:10.32607/actanaturae.27707 · Cited by 14

Comprehensive Overview of Vaccines and Theirtypes for Human Immunization

Burghate, S., & Mundada, A. (2023) · Bulletin of pioneering researches of medical and clinical science · doi:10.51847/r1jq49ozbm · Cited by 14

Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine

Ping, H., Yu, W., Gong, X., Tong, X., Lin, C., Chen, Z., Cai, C., Guo, K., & Ke, H. (2022) · Investigational New Drugs · doi:10.1007/s10637-022-01290-y · Cited by 14

Uniting Disciplines to Develop Therapeutics: Targeted mRNA Lipid Nanoparticles Reprogram the Immune System In Vivo to Treat Heart Disease

Rurik, J. G., & Epstein, J. A. (2022) · DNA and Cell Biology · doi:10.1089/dna.2022.0171 · Cited by 13

“All-in-One” Exosome Engineering Strategy for Effective Therapy of Familial Hypercholesterolemia

Mei, R., Wan, Z., Li, Z., Wei, M., Qin, W., Yuan, L., Liu, L., & Yang, G. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c15785 · Cited by 13

Non-viral delivery of RNA for therapeutic T cell engineering

Berdecka, D., Smedt, S. C. D., Vos, W. H. D., & Braeckmans, K. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115215 · Cited by 14

mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option

Niazi, S. K., & Magoola, M. (2023) · Biologics · doi:10.3390/biologics3040020 · Cited by 13

Antibody production by in vivo RNA transfection

Romani, B., Kavyanifard, A., & Allahbakhshi, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-11399-3 · Cited by 14

mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases

Brandi, R., Paganelli, A., D’Amelio, R., Giuliani, P., Lista, F. R., Salemi, S., & Paganelli, R. (2024) · Vaccines · doi:10.3390/vaccines12121418 · Cited by 13

Race with virus evolution: The development and application of mRNA vaccines against SARS-CoV-2

Lee, K.-M., Lin, S., Wu, C.-J., & Kuo, R. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.01.002 · Cited by 14

IL-10 modified mRNA monotherapy prolongs survival after composite facial allografting through the induction of mixed chimerism

Aviña, A. E., Paz, D. D., Huang, S.-C., Chen, K., Chang, Y., Lee, C.-M., Lin, C.-H., Wei, F., & Wang, A. Y. L. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.02.016 · Cited by 12

The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize

Janowski, M., & Andrzejewska, A. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.07.003 · Cited by 12

Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape

Miliotou, Α. N., Georgiou‐Siafis, S. K., Ntenti, C., Pappas, I. S., & Papadopoulou, L. C. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110576 · Cited by 12

Synthetic mRNA: Production, Introduction into Cells, and Physiological Consequences

Rhoads, R. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3625-0_1 · Cited by 11

Reduced expression of α2C-adrenoceptors in rat striatum following antisense oligodeoxynucleotide infusion

Lu, L., & Ordway, G. A. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00057-0 · Cited by 11

Neurotransmitter Receptors in Developing Barrel Cortex

Fuchs, J. L. (1995) · Cerebral cortex · doi:10.1007/978-1-4757-9616-2_9 · Cited by 11

Development and Application of Automated Sandwich ELISA for Quantitating Residual dsRNA in mRNA Vaccines

Holland, D. A., Acevedo‐Skrip, J., Barton, J. R., Thompson, R., Bowman, A. M., Dewar, E. A., Miller, D. V., Zhao, K., Swartz, A. R., & Loughney, J. W. (2024) · Vaccines · doi:10.3390/vaccines12080899 · Cited by 10

Towards mRNA therapeutics 2.0

Chien, K. R., Foo, K. S., & Witman, N. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01459-7 · Cited by 12

At the nexus of science, engineering, and medicine: Pasteur's quadrant reconsidered

Pettigrew, R. I., & Cooke, J. P. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac092 · Cited by 10

Split-Dose Administration Enhances Immune Responses Elicited by a mRNA/Lipid Nanoparticle Vaccine Expressing Respiratory Syncytial Virus F Protein

Austin, L. A., Smith, J. S., Nahas, D. D., Danzinger, A., Secore, S., O’Donnell, G. T., Radcliffe, S., Hu, S., Perley, J., Bett, A. J., et al. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00635 · Cited by 10

Advancements in gene therapy approaches for atrial fibrillation: Targeted delivery, mechanistic insights and future prospects

Khawajakhail, R., Khan, R. U., Gondal, M. U. R., Toru, H. K., Malik, M., Iqbal, A., Malik, J., Faraz, M., & Awais, M. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102431 · Cited by 10

Antisense: into the brain

Harrison, P. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91812-z · Cited by 10

Dendritic and axonal mRNA trafficking

Mohr, E., & Richter, D. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90176-9 · Cited by 10

Emerging trends of research on mRNA vaccines: A co-citation analysis

Chen, J., Zhang, T., Lu, Y. Z., Yang, X., & Ouyang, Z. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2110409 · Cited by 10

Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response

Costa, G. L., & Sautto, G. A. (2025) · Expert Review of Vaccines · doi:10.1080/14760584.2025.2452955 · Cited by 8

Novel TNF-α-targeting mRNA therapy for sustained psoriasis treatment and relapse prevention by suppressing IL-15-TRM signaling

Li, X., Shao, X., Li, X., Chen, Q., Zang, Y., Wang, J., Yang, Y., Qiang, L., Lin, A., & He, Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114218 · Cited by 8

Clinical Analysis and Applications of mRNA Vaccines in Infectious Diseases and Cancer Treatment

Ankrah, P. K., Ilesanmi, A. O., Akinyemi, A. O., Lasehinde, V., Adurosakin, O. E., & Ajayi, O. H. (2023) · Cureus · doi:10.7759/cureus.46354 · Cited by 8

Recent advances in gene therapy for atrial fibrillation

Yoo, S., Geist, G. E., Pfenniger, A., Rottmann, M., & Arora, R. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15116 · Cited by 8

Regulation of Serotonin2A Receptor Expression by an Antisense Oligodeoxynucleotide

Scalzitti, J. M., Berg, K. A., Kratowicz, S. A., & Hensler, J. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041457.x · Cited by 8

Ethical implications of developing RNA-based therapies for cardiovascular disorders

Hostiuc, M., Scafa‐Udriște, A., Iancu, B., Iancu, D., Isailă, O.-M., Ion, O. M., Stroe, A., Diaconu, C. C., Epistatu, D., & Hostiuc, S. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1370403 · Cited by 7

Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies

Costa, V., Costa, S. M., Saramago, M., Cunha, M. V., Arraiano, C. M., Viegas, S. C., & Matos, R. G. (2022) · Microorganisms · doi:10.3390/microorganisms10112303 · Cited by 8

Ultrastructural Immunogold Cytochemistry with Autoimmune Human Sera and an Antibody to Uridine Implicate Human Mast Cell Granules in RNA Biology

Dvořàk, A. M., & Morgan, E. S. (2000) · The Histochemical Journal · doi:10.1023/a:1004119500801 · Cited by 7

Advancement insights in cancer vaccines: mechanisms, types, and clinical applications

Kamel, G. A. M., Attia, R. A. H., Al-Noman, H. G., & Salama, L. A. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10370-0 · Cited by 6

Progress in vaccine development for infectious diseases—a Keystone Symposia report

Cable, J., Graham, B. S., Koup, R. A., Seder, R. A., Karikó, K., Pardi, N., Barouch, D. H., Sharma, B., Rauch, S., Nachbagauer, R., et al. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14975 · Cited by 8

Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history

Pascolo, S. (2023) · European Journal of Immunology · doi:10.1002/eji.202249941 · Cited by 6

mRNA-based vaccines – global approach, challenges, and could be a promising wayout for future pandemics

Makhijani, S., Elossaily, G. M., Rojekar, S. V., & Ingle, R. G. (2024) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2024.2361656 · Cited by 7

Next-Generation Therapeutics: mRNA as a Novel Therapeutic Option for Single-Gene Disorders

Michel, T., Wendel, H.-P., & Krajewski, S. (2016) · InTech eBooks · doi:10.5772/62243 · Cited by 7

Reduction of exogenous vasopressin RNA poly(A) tail length increases its effectiveness in transiently correcting diabetes insipidus in the Brattleboro rat.

Maciejewski-Lenoir, D., Jirikowski, G. F., Sanna, P. P., & Bloom, F. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1435 · Cited by 29

Vasopressin gene is expressed at low levels in the hypothalamus of the Brattleboro rat.

Majzoub, J. A., Pappey, A., Burg, R., & Habener, J. F. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5296 · Cited by 47

Vasopressin Antisense Oligonucleotide Induces Temporary Diabetes Insipidus in Rats

Skutella, T., Probst, J. C., Engelmann, M., Wotjak, G. T., Landgraf, R., & Jirikowski, G. F. (1994) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1994.tb00561.x · Cited by 30

Defective regulation of vasopressin gene expression in Brattleboro rats

Majzoub, J. A., Carrazana, E. J., SHULMAN, J., Baker, K. J., & Emanuel, R. L. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.5.e637 · Cited by 24

In situ hybridization demonstrates vasopressin gene transcription in hypothalamic neurons of crossbred hypertensive × diabetes insipidus rats

McCabe, J. T., Almasan, K., Lehmann, E., ̈nze, J. H., Lang, R. E., Pfaff, D. W., & Ganten, D. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90226-6 · Cited by 11